We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

202 hedge funds and large institutions have $1.03B invested in PDL BioPharma, Inc. in 2013 Q2 according to their latest regulatory filings, with 202 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $1.09M

Holders
202
Holders Change
+202
Holders Change %
–
% of All Funds
6.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
202
Increased
–
Reduced
–
Closed
–
Calls
$2.13M
Puts
$1.09M
Net Calls
+$1.04M
Net Calls Change
+$1.04M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WBC
76
Westpac Banking Corp
Australia
$1.54M +$1.65M +211,308 New
JIR
77
James Investment Research
Ohio
$1.46M +$1.47M +188,765 New
SFM
78
Systematic Financial Management
New Jersey
$1.43M +$1.45M +185,412 New
Fiera Capital (Canada)
79
Fiera Capital (Canada)
Quebec, Canada
$1.35M +$1.36M +174,700 New
PI
80
Putnam Investments
Massachusetts
$1.34M +$1.36M +173,861 New
AIA
81
Affinity Investment Advisors
California
$1.33M +$1.34M +172,135 New
BNP Paribas Financial Markets
82
BNP Paribas Financial Markets
France
$1.32M +$1.33M +171,137 New
ZCM
83
Zebra Capital Management
Connecticut
$1.27M +$1.28M +163,984 New
ACI
84
AMP Capital Investors
Australia
$1.24M +$1.26M +161,000 New
GC
85
Globeflex Capital
California
$1.22M +$1.24M +158,556 New
SO
86
STRS Ohio
Ohio
$1.15M +$1.16M +149,000 New
RhumbLine Advisers
87
RhumbLine Advisers
Massachusetts
$1.14M +$1.15M +148,061 New
CIBC World Market
88
CIBC World Market
Ontario, Canada
$1.05M +$1.06M +136,249 New
Macquarie Group
89
Macquarie Group
Australia
$976K +$986K +126,452 New
Swiss National Bank
90
Swiss National Bank
Switzerland
$948K +$958K +122,800 New
ProShare Advisors
91
ProShare Advisors
Maryland
$934K +$943K +120,966 New
MLICM
92
Metropolitan Life Insurance Company (MetLife)
New York
$920K +$929K +119,167 New
AIG
93
American International Group
New York
$829K +$838K +107,447 New
NFA
94
Nationwide Fund Advisors
Ohio
$822K +$830K +106,461 New
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$751K +$759K +97,301 New
Millennium Management
96
Millennium Management
New York
$712K +$719K +92,225 New
Prudential Financial
97
Prudential Financial
New Jersey
$708K +$715K +91,735 New
VOYA Investment Management
98
VOYA Investment Management
Georgia
$707K +$714K +91,630 New
Neuberger Berman Group
99
Neuberger Berman Group
New York
$669K +$675K +86,604 New
AAA
100
Adams Asset Advisors
Texas
$667K +$674K +86,450 New
2 3
4
5 6

PDLI Hedge Fund Activity: Q2 2013 in Review

202 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q2 2013, worth a combined $1.03B.

Buyers outnumbered sellers: 202 funds opened new PDLI positions and 0 closed out — a net gain of 202 holders — while 0 added to existing stakes and 0 trimmed.

  • 202 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.03B of PDL BioPharma, Inc. stock for Q2 2013.
  • 202 funds opened new PDL BioPharma, Inc. positions in Q2 2013 and 0 closed out, a net change of +202 holders.

Based on aggregated 13F filings for Q2 2013.